Benatti Luca
SEC insider (Form 3/4/5 filer). CIK 0001613842. Director at Quince Therapeutics, Inc. (QNCX). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 26, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Benatti Luca has filed insider reports for
- Quince Therapeutics, Inc. (QNCX): Director
Benatti Luca
CIK: 0001613842
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
QNCX
Quince Therapeutics, Inc.
Director